PROT.US Proteonomix Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 12, 2026
0.0001 0.0001
Market cap
USD 791.00
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2012.

Is PROT.US undervalued?

Graham number

The Graham number of Proteonomix Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Proteonomix Inc fundamental analysis

No fundamental analysis for Proteonomix Inc yet.

Proteonomix Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Proteonomix Inc

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two we…

Full company profile